Medical directors of cardiac catheterization (CC) and electrophysiology (EP) laboratories play an important role in the selection of devices and medications available within hospital procedural areas. This may also influence the practice patterns of their colleagues. As such, payments made from industry to medical directors of CC and EP laboratories have the potential to create conflicts of interest (COIs). The National Academy of Medicine (previously the Institute of Medicine) defines a COI as an event where “an individual or institution has a secondary interest that creates a risk of undue influence on decisions or actions affecting a primary interest,”1(p26) and notes that any payment of $10 000 or more constitutes a significant COI.1 However, to our knowledge, the extent and nature of payments to laboratory directors from top-ranking institutions has not been described previously.
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Annapureddy A, Sengodan P, Mahajan S, et al. Distribution of Industry Payments Among Medical Directors of Catheterization and Electrophysiology Laboratories From the Top 100 US Hospitals. JAMA Intern Med. Published online June 17, 2019179(9):1282–1284. doi:10.1001/jamainternmed.2018.8775
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: